切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2018, Vol. 07 ›› Issue (03) : 270 -275. doi: 10.3877/cma.j.issn.2095-3224.2018.03.015

所属专题: 文献

综述

麻醉对肿瘤患者免疫功能及术后肿瘤复发和转移的影响
吴蔽野1, 郑晖1,()   
  1. 1. 100021 北京,国家癌症中心/中国医学科学院北京协和医学院肿瘤医院麻醉科
  • 收稿日期:2017-12-09 出版日期:2018-06-25
  • 通信作者: 郑晖
  • 基金资助:
    中国医学科学院肿瘤医院人才发展经费奖励项目(No.N04165)

Effects of anesthesia on the immune system of tumor patients and postoperative period malignant tumor recurrence and metastasis

Biye Wu1, Hui Zheng1,()   

  1. 1. Department of Anesthesiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • Received:2017-12-09 Published:2018-06-25
  • Corresponding author: Hui Zheng
  • About author:
    Corresponding author: Zheng Hui, Email:
引用本文:

吴蔽野, 郑晖. 麻醉对肿瘤患者免疫功能及术后肿瘤复发和转移的影响[J/OL]. 中华结直肠疾病电子杂志, 2018, 07(03): 270-275.

Biye Wu, Hui Zheng. Effects of anesthesia on the immune system of tumor patients and postoperative period malignant tumor recurrence and metastasis[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2018, 07(03): 270-275.

近年来,肿瘤发生率明显上升,目前手术仍是治疗多种恶性肿瘤的主要方式。术后原发肿瘤的复发和转移是患者预后不良的主要原因之一。研究表明患者自身免疫系统功能与肿瘤的发生发展相互作用。麻醉作为围术期不可或缺的一部分,与患者免疫系统功能及术后肿瘤复发转移之间存在复杂关联。本文阐述了多种麻醉方式和麻醉药物与肿瘤患者免疫功能的相互作用及对肿瘤患者术后转移和复发的影响。

In recent years, the incidence of tumor has risen apparently, and for most of malignant tumor patients, they undergo surgical procedures. The recurrence and metastasis of primary tumor after operation is one of the main causes of poor prognosis. Studies show that the function of the patient′s immune system is interacting with the development of the tumor. As an integral part of the perioperative period, anesthesia has a complex relationship with the immune system and the recurrence and metastasis of the malignant tumor during the postoperative period. In this review, we describe the effects of various anesthetic methods and narcotic drugs on the immune system of the tumor patients and the postoperative metastasis and recurrence of tumor patients.

[1]
Torre LA, Siegel RL, Ward EM, et al. Global Cancer Incidence and Mortality Rates and Trends-An Update [J]. Cancer Epidemiology Biomarkers & Prevention, 2016, 25(1): 16-27.
[2]
Cali B, Molon B, Viola A. Tuning cancer fate: the unremitting role of host immunity [J]. Open Biol, 2017, 7(4): 1-12.
[3]
Vallejo R, Hord E D, Barna S A, et al. Perioperative immunosuppression in cancer patients [J]. Journal of Environmental Pathology Toxicology & Oncology Official Organ of the International Society for Environmental Toxicology & Cancer, 2003, 22(2): 139-146.
[4]
Lafont V, Sanchez FO, Laprevotte E, et al. Plasticity of γδ T Cells: Impact on the Anti-Tumor Response [J]. Frontiers in Immunology, 2014, 5: 622.
[5]
Paul WE, Zhu JF. How are TH2-type immune responses initiated and amplified? [J]. Nat Rev Immunol, 2010, 10(4): 225-235.
[6]
Davis MM, Krogsgaard M, Huse M, et al. T cells as a self-referential, sensory organ [J]. Annu Rev Immunol, 2007, 25: 681-695.
[7]
Boland J W, Pockley A G. Influence of opioids on immune function in patients with cancer pain: from bench to bedside [J]. British Journal of Pharmacology, 2017: 1-11.
[8]
Lin X, Wang Y, Li Q, et al. Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway [J]. FEBS Journal, 2009, 276(7): 2022-2036.
[9]
Kurosawa S. Anesthesia in patients with cancer disorders [J]. Current Opinion in Anaesthesiology, 2012, 25(3): 376-384.
[10]
Wada H, Seki S, Takahashi T, et al. Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance [J]. Anesthesiology, 2007, 106(3): 499-506.
[11]
Karmakar M K, Samy W, Lee A, et al. Survival Analysis of Patients with Breast Cancer Undergoing a Modified Radical Mastectomy With or Without a Thoracic Paravertebral Block: a 5-Year Follow-up of a Randomized Controlled Trial [J]. Anticancer Research, 2017, 37(10): 5813-5820.
[12]
Chen X, Lu P, Chen L, et al. Perioperative propofol-paravertebral anesthesia decreases the metastasis and progression of breast cancer [J]. Tumour Biol, 2015, 36(11): 8259-8266.
[13]
战珑,韩建阁. 吸入性麻醉药和静脉麻醉药及其副作用研究新进展 [J]. 实用临床医药杂志, 2015, (13): 200-202.
[14]
Ash SA, Valchev GI, Looney M, et al. Xenon decreases cell migration and secretion of a pro-angiogenesis factor in breast adenocarcinoma cells: comparison with sevoflurane [J]. British Journal of Anaesthesia, 2014, 113(suppl 1): i14-i21.
[15]
Sanders RD, Weimann J, Maze M. Biologic Effects of Nitrous Oxide [J]. Anesthesiology, 2008, 109(4): 707-722.
[16]
Benzonana L L, Perry N J S, Watts H R, et al. Isoflurane, a Commonly Used Volatile Anesthetic, Enhances Renal Cancer Growth and Malignant Potential via the Hypoxia-inducible Factor Cellular Signaling Pathway In Vitro [J]. Anesthesiology, 2013, 119(3): 593-605.
[17]
Zhu M, Li M, Zhou Y, et al. Isoflurane enhances the malignant potential of glioblastoma stem cells by promoting their viability, mobility in vitro and migratory capacity in vivo [J]. British Journal of Anaesthesia, 2016, 116(6): 870-877.
[18]
Guo N, Zhang J, Wu J, et al. Isoflurane promotes glucose metabolism through up-regulation ofmiR-21 and suppresses mitochondrial oxidative phosphorylation in ovarian cancer cells [J]. Bioscience Reports, 2017, 37(6): R20170818.
[19]
Mülleredenborn B, Graggen BR, Bartnicka K, et al. Volatile anesthetics reduce invasion of colorectal cancer cells through down-regulation of matrix metalloproteinase-9 [J]. Anesthesiology, 2012, 117(2): 293-301.
[20]
Ohta N, Ohashi Y, Fujino Y. Ketamine inhibits maturation of bone marrow-derived dendritic cells and priming of the Th1-type immune response [J]. Anesth Analq, 2009, 109(3): 793-800.
[21]
Forget P, Collet V, Lavandʼhomme P, et al. Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages [J]. European Journal of Anaesthesiology, 2010, 27(3): 233-240.
[22]
He H, Chen J, Xie W P, et al. Ketamine used as an acesodyne in human breast cancer therapy causes an undesirable side effect, upregulating anti-apoptosis protein Bcl-2 expression [J]. Genetics and molecular research : GMR, 2013, 12(2): 1907.
[23]
Inada T, Kubo K, Shingu K. Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol [J]. J Anesth, 2011, 25(4): 569-575.
[24]
Yang N, Liang Y, Yang P, et al. Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression [J]. Braz J Med Biol Res, 2017, 50(1): e5794.
[25]
Liu S, Gu X, Zhu L, et al. Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer [J]. Medicine, 2016, 95(49): e5479.
[26]
Le G G, Angenard G, Clément B, et al. Local Anesthetics Inhibit the Growth of Human Hepatocellular Carcinoma Cells [J]. Anesthesia-Analgesia, 2017, 125(5): 1600-1609.
[27]
闫洪彦,张俊华,黄宇光. 镇痛与免疫内在关系的研究进展 [J]. 国际麻醉学与复苏杂志, 2008, 29(2): 146-148.
[28]
Buckley A, Mcquaid S, Johnson P, et al. Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: a pilot study [J]. British Journal of Anaesthesia, 2014, 113: i56-i62.
[29]
Koodie L, Yuan H, Pumper JA, et al. Morphine inhibits migration of tumor-infiltrating leukocytes and suppresses angiogenesis associated with tumor growth in mice [J]. Am J Pathol, 2014, 184(4): 1073-1084.
[30]
Yamamizu K, Furuta S, Hamada Y, et al. к Opioids inhibit tumor angiogenesis by suppressing VEGF signaling [J]. Scientific Reports, 2013, 3(1): 3213.
[31]
Ou W, Lv J, Zou X, et al. Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2-mediated Wnt/β-catenin pathway [J]. Exp Ther Med, 2017, 13(5): 2501-2506.
[32]
Finn D M, Ilfeld B M, Unkart J T, et al. Post-mastectomy cancer recurrence with and without a continuous paravertebral block in the immediate postoperative period: a prospective multi-year follow-up pilot study of a randomized, triple-masked, placebo-controlled investigation [J]. Journal of Anesthesia, 2017, 31(3): 374-379.
[33]
Piegeler T, Votta-Velis E G, Liu G, et al. Antimetastatic Potential of Amide-linked Local Anesthetics [J]. Anesthesiology, 2012, 117(3): 548-559.
[34]
Lucchinetti E, Awad AE, Rahman M, et al. Antiproliferative Effects of Local Anesthetics on Mesenchymal Stem Cells [J]. Anesthesiology, 2012, 116(4): 841-856.
[35]
Chang YC, Liu CL, Chen MJ, et al. Local anesthetics induce apoptosis in human breast tumor cells [J]. Anesth Analq, 2014, 118(1): 116-124.
[36]
Yoon JR, Whipple RA, Balzer EM, et al. Local anesthetics inhibit kinesin motility and microtentacle protrusions in human epithelial and breast tumor cells [J]. Breast Cancer Res Treat, 2011, 129(3): 691-701.
[37]
Iwaszkiewicz KS, Schneider JJ, Hua S. Targeting peripheral opioid receptors to promote analgesic and antiinflammatory actions [J]. Front Pharmacol, 2013, 4: 132.
[38]
Iwasaki M, Edmondson M, Sakamoto A, et al. Anesthesia, surgical stress, and ″long-term″ outcomes [J]. Acta Anaesthesiologica Taiwanica, 2015, 53(3): 99-104.
[39]
Sun Y, Li T, Gan T J. The Effects of Perioperative Regional Anesthesia and Analgesia on Cancer Recurrence and Survival After Oncology Surgery [J]. Regional Anesthesia and Pain Medicine, 2015, 40(5): 589-598.
[40]
Boland J W, Pockley A G. Influence of opioids on immune function in patients with cancer pain: from bench to bedside [J]. British Journal of Pharmacology, 2017, 139(03): 1-11.
[41]
Jang D, Lim C S, Shin Y S, et al. A comparison of regional and general anesthesia effects on 5 year survival and cancer recurrence after transurethral resection of the bladder tumor: a retrospective analysis [J]. BMC Anesthesiology, 2016, 16: 16.
[42]
Borgeat A. Regional anaesthesia and cancer metastases: the implication of local anaesthetics [J]. Acta Anaesthesiologica Scandinavica, 2014, 58(2): 262.
[43]
Xu Y J, Chen W K, Zhu Y, et al. Effect of thoracic epidural anaesthesia on serum vascular endothelial growth factor C and cytokines in patients undergoing anaesthesia and surgery for colon cancer [J]. BJA: British Journal of Anaesthesia, 2014, 113(suppl_1): i49-i55.
[1] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[2] 宋玟焱, 杜美君, 陈佳丽, 石冰, 黄汉尧. 唇腭裂手术围手术期疼痛管理的研究进展及基于生物材料治疗新方法的展望[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 397-405.
[3] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[4] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[5] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[6] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[7] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[8] 韩婧, 郝少龙, 康骅. 北京市单中心甲状腺癌患者临床特征的回顾分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 490-493.
[9] 杜伟, 廖土明, 李雄才, 关刚强, 何燊, 吴佳桥, 朱和荣. 2%利多卡因凝胶和润滑剂凝胶在女性尿流动力学检查中应用的随机对照研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 613-617.
[10] 林逸, 钟文龙, 李锴文, 何旺, 林天歆. 广东省医学会泌尿外科疑难病例多学科会诊(第15期)——转移性膀胱癌的综合治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 648-652.
[11] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[12] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[13] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[14] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[15] 王曦娅, 尹弘青, 丁伟, 徐滨, 于海源, 马东升, 邵军. 桥本背景下甲状腺乳头状癌多参数分析预测大容量淋巴结转移[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 548-554.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?